Fleming's Original Penicillin Culture Sold at Auction

Bidder pays big bucks for the revolutionary antibiotic

Join Our Community of Science Lovers!

A small sample of Sir Alexander Fleming's original penicillin culture (above) was put up for sale by a London auction house in July. In 1955 Fleming had given the fungus to a neighbor to thank him for foiling a robbery at the famed microbiologist's home. Fleming stumbled on the antibiotic properties of Penicillium mold in 1928, and over the course of the following decade University of Oxford bacteriologists and others expanded on his findings to develop the first antibiotic drug. Mass production of penicillin during World War II cured millions of people of bacterial infections that would have been fatal otherwise. Today antibiotics are considered one of the greatest discoveries in medical history—thus the auction of a crusty petri dish that would have been thrown out long ago. In a letter accompanying the sample, the microbiologist's housekeeper warned its recipient that the contents were “not to be confused with Gorgonzola cheese!!!”

By the Numbers

$20

On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.

Cost per 100,000 units of penicillin in 1943. With mass production, that price fell to less than 10 cents by 1949.

6.8 trillion

Units of the antibiotic produced by U.S. companies in 1945.

Percentage of deaths attributed to bacterial pneumonia in World War II, down from 18 percent in World War I.

20+

Classes of antibiotics introduced since penicillin became available.

£4,649

Price paid by the highest bidder for Fleming's original culture.

SOURCES FOR STATISTICS: DISCOVERY AND DEVELOPMENT OF PENICILLIN, IN AMERICAN CHEMICAL SOCIETY'S INTERNATIONAL HISTORIC CHEMICAL LANDMARKS www.acs.org/content/acs/en/education/whatischemistry/landmarks/flemingpenicillin.html (first two items); “THE REAL STORY BEHIND PENICILLIN,” BY HOWARD MARKEL, IN PBS NEWSHOUR'S “THE RUNDOWN.” PUBLISHED ONLINE SEPTEMBER 27, 2013 www.pbs.org/newshour/rundown/the-real-story-behind-the-worlds-first-antibiotic (third item); “NEW BUSINESS MODELS FOR ANTIBIOTIC INNOVATION,” BY ANTHONY D. SO AND TEJEN A. SHAH, IN UPSALA JOURNAL OF MEDICAL SCIENCES, VOL. 119, NO. 2; MAY 2014 (fourth item); CATHERINE SOUTHON AUCTIONEERS & VALUERS (fifth item)

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American